{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-23-022716","form_type":"8-K","ticker":"NUS","cik":"0001021561","company_name":"NU SKIN ENTERPRISES, INC.","filed_at":"2023-05-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:37.632254+00:00","generated_at":"2026-06-15T23:55:39.590686+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Nu Skin Q1 2023 revenue $481.5M (-20% YoY), EPS $0.23 vs $0.76; reaffirms FY guidance","bullets":["Revenue fell 20% to $481.5M; GAAP EPS $0.23 declined from $0.76; adjusted EPS $0.37 ex restructuring.","Customers down 18% to 1.08M; paid affiliates -12% to 221,354; sales leaders -17% to 43,755.","Q1 operating margin 3.3% (5.4% ex-items); recognized $9.8M restructuring and impairment charges.","Q2 2023 guidance: revenue $485-525M, EPS $0.45-$0.55. FY revenue $2.03-2.18B, EPS $2.27-2.67.","Paid $19.4M in dividends; $175.4M remaining in stock repurchase authorization."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-23-022716","json":"https://secwatch.observer/filing/0001140361-23-022716.json","markdown":"https://secwatch.observer/filing/0001140361-23-022716.md","text":"https://secwatch.observer/filing/0001140361-23-022716.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1021561/000114036123022716/0001140361-23-022716-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1021561/000114036123022716/brhc20052418_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T23:55:39.590686+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ff55add16ad49d6d9203d33c2723fcf60c5599c8","claim":"NU SKIN ENTERPRISES, INC. updated its first quarter 2023 guidance (reaffirmed).","evidence_excerpt":"On May 3, 2023, Nu Skin Enterprises, Inc. (the “Company”) issued a press release announcing its financial results for the three-month period ended March 31, 2023, and certain other information. A copy of the press release is attached as Exhibit 99.1 to this report.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1021561/000114036123022716/0001140361-23-022716-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter 2023"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}